Skip to content Skip to navigation
University of Warwick
  • Study
  • |
  • Research
  • |
  • Business
  • |
  • Alumni
  • |
  • News
  • |
  • About

University of Warwick
Publications service & WRAP

Highlight your research

  • WRAP
    • Home
    • Search WRAP
    • Browse by Warwick Author
    • Browse WRAP by Year
    • Browse WRAP by Subject
    • Browse WRAP by Department
    • Browse WRAP by Funder
    • Browse Theses by Department
  • Publications Service
    • Home
    • Search Publications Service
    • Browse by Warwick Author
    • Browse Publications service by Year
    • Browse Publications service by Subject
    • Browse Publications service by Department
    • Browse Publications service by Funder
  • Help & Advice
University of Warwick

The Library

  • Login
  • Admin

Topical (intra-articular) tranexamic acid reduces blood loss and transfusion rates following total knee replacement : a randomized controlled trial (TRANX-K)

Tools
- Tools
+ Tools

Alshryda, Sattar, Mason, James, Vaghela, Manesh, Sarda, Praveen, Nargol, Antoni, Maheswaran, S, Tulloch, Chris, Anand, Sanjeev, Logishetty, Raj, Stothart, Brian and Hungin, A Pali S. (2013) Topical (intra-articular) tranexamic acid reduces blood loss and transfusion rates following total knee replacement : a randomized controlled trial (TRANX-K). The Journal of Bone and Joint Surgery, 95 (21). pp. 1961-1968. doi:10.2106/JBJS.L.00907

Research output not available from this repository, contact author.
Official URL: http://dx.doi.org/10.2106/JBJS.L.00907

Request Changes to record.

Abstract

Background: Approximately one-third of patients undergoing total knee replacement require one to three units of blood postoperatively. Tranexamic acid (TXA) is a synthetic antifibrinolytic agent that has been successfully used intravenously to stop bleeding after total knee replacement. A topical application is easy to administer, provides a maximum concentration of tranexamic acid at the bleeding site, and is associated with little or no systemic absorption of the tranexamic acid.

Methods: A double-blind, randomized controlled trial of 157 patients undergoing unilateral primary cemented total knee replacement investigated the effect of topical (intra-articular) application of tranexamic acid on blood loss. The primary outcome was the blood transfusion rate. Secondary outcomes included the drain blood loss, hemoglobin concentration drop, generic quality of life (EuroQol), Oxford Knee Score, length of stay, a cost analysis, and complications as per the protocol definitions.

Results: Tranexamic acid reduced the absolute risk of blood transfusion by 15.4% (95% confidence interval [CI], 7.5% to 25.4%; p = 0.001), from 16.7% to 1.3%, and reduced blood loss by 168 mL (95% CI, 80 to 256 mL; p = 0.0003), the length of stay by 1.2 days (95% CI, 0.05 to 2.43 days; p = 0.041), and the cost per episode by £333 (95% CI, £37 to £630; p = 0.028). (In 2008, £1 = 1.6 U.S. dollars.) Oxford Knee Scores and EuroQol EQ-5D scores were similar at three months.

Conclusions: Topically applied tranexamic acid was effective in reducing the need for blood transfusion following total knee replacement without important additional adverse effects.

Level of Evidence: Therapeutic Level I. See Instructions for Authors for a complete description of levels of evidence.

Item Type: Journal Article
Divisions: Faculty of Medicine > Warwick Medical School > Health Sciences
Faculty of Medicine > Warwick Medical School
Journal or Publication Title: The Journal of Bone and Joint Surgery
Publisher: The Journal of Bone & Joint Surgery
ISSN: 0021-9355
Official Date: November 2013
Dates:
DateEvent
November 2013Published
Volume: 95
Number: 21
Page Range: pp. 1961-1968
DOI: 10.2106/JBJS.L.00907
Status: Peer Reviewed
Publication Status: Published
Access rights to Published version: Restricted or Subscription Access

Request changes or add full text files to a record

Repository staff actions (login required)

View Item View Item
twitter

Email us: wrap@warwick.ac.uk
Contact Details
About Us